Reserpine versus beta-blocker as an additive to a diuretic in the treatment of Kenyan hypertensives.
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001262:Atenolol / Q000627:therapeutic use; D002752:Chlorthalidone / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D011799:Quinazolines / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use; D013449:Sulfonamides
D000959:Antihypertensive Agents; D004232:Diuretics; D004338:Drug Combinations; D011799:Quinazolines; D013449:Sulfonamides; C035884:atenolol, chlortalidone drug combinations; C050700:quinethazone; D001262:Atenolol; D012110:Reserpine; D002752:Chlorthalidone